KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Moderna (MRNA) Preferred Shares Issued (2018)

Moderna (MRNA) has disclosed Preferred Shares Issued for 1 consecutive years, with $111.6 million as the latest value for Q2 2018.

  • Quarterly Preferred Shares Issued changed N/A to $111.6 million in Q2 2018 from the year-ago period, while the trailing twelve-month figure was $111.6 million through Mar 2019, changed N/A year-over-year, with the annual reading at $661.1 million for FY2018, N/A changed from the prior year.
  • Preferred Shares Issued for Q2 2018 was $111.6 million at Moderna, down from $549.5 million in the prior quarter.
  • The five-year high for Preferred Shares Issued was $549.5 million in Q1 2018, with the low at $111.6 million in Q2 2018.